· Published by Health Canada · Official notice
This is duplicated text of a letter issued by the Therapeutic Products Directorate, Medical Devices Bureau.
Contact the company for a copy of any references, attachments or enclosures.
Notice about Health Canada advisories
April 29, 2002
Fast-Check HIV-1/2 (serum) & Fast-Check HIV-1/2 (whole blood) manufactured by BioChem ImmunoSystems Inc.
To:
Directors, Provincial Health Laboratories
Directors, Clinics
Physicians
Canadian Medical Association
Dear Health Professional,
The purpose of this advisory is to inform you that performance problems have been identified with the Fast-Check HIV-1/2 (serum) assay, Licence No.18490, and the Fast-Check HIV1/2 (whole blood) which is intended for Point of Care testing, Licence No.18498. Both assays are manufactured by BioChem ImmunoSystems Inc. of Montreal, Canada. The performance problems are related to the sensitivity of the assay as false negative results have been identified.
As a result of testing carried out by B.C. Centre for Disease Control, Health Canada has requested BioChem ImmunoSystems to stop sale of the Fast-Check HIV-1/2 (whole blood) assay and Fast-Check HIV-1/2 (serum) assay. BioChem ImmunoSystems has initiated the recall of the Fast-Check HIV-1/2 (serum) assay Lot No. 2202077.
Health Canada is reviewing the situation across the country and working closely with the manufacturer and users of the kits to investigate the cause(s) of the problem. Health Canada will assess the adequacy of any corrective and preventive actions proposed by BioChem ImmunoSystems Inc. and will take appropriate action.
In the interest of public health, Health Canada is seeking your cooperation by implementing the following recommendations:
Recommendations:
Health Canada will inform you of any changes to these recommendations as a result of the ongoing investigation.
Contacts:
Individuals seeking additional information on the recall of this product or individuals with information related to patient tracing should leave a message on the Inspectorate Hotline at 1-800-267-9675. A Health Canada official will return your call.
Individuals seeking information on testing algorithms should contact Dr. John Kim, Chief, National Laboratory for HIV References Services at 613-957-9666.
The manufacturer can be contacted at:
BioChem ImmunoSystems Inc.
10900 Hamon Street
Montreal, Quebec
H3M 3A2
Tel: 514-335-9922
Fax: 514-335-9919
original signed by
Roland Rotter, Ph.D.
A/Director, Medical Devices Bureau
roland_rotter@hc-sc.gc.ca
Tel: 613 957-4786
Any suspected adverse incident can also be reported to:
The Health Products & Food Branch Inspectorate Hotline 1-800-267-9675